Asia Pacific HIV Clinical Forum 2019 – Presentations

 

Day 1 - Wednesday, 26 June 2019

 Session 1: Integrase Inhibitors: State of the Art
Chair: Patrick Li & Kiat Ruxrungtham
 

Boucher, Charles 2017Selected INSTI Highlights - CROI 2019
Charles Boucher, MD, PhD
Erasmus Medical Center, Rotterdam

 Schapiro Photo 2008Barrier to Resistance and Implications for Treatment
(No permission for publication)

Jonathan Schapiro, MD
Sheba Medical Center, Ramat Gan
 The impact of antiretroviral drug resistance in Taiwanese HIV-1-infected MSM population between 2015 and 2018
Abstract | 01
Yen-Ju Chen
National Yang-Ming University, Taiwan
 Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-Tablet Antiretroviral Regimens
Kuan-Yeh Lee
National Taiwan University College of Medicine, Taiwan
  
 Session 2: Clinical Utility of Integrase Inhibitors
Chair: Saye Khoo & Grace Lui
  Oka, Shinich 2015_120Clinical experience INSTI in Japan
Shinichi Oka, MD, PhD
National Center for Global Health and Medice, Tokyo
 Clinical experience INSTI in Korea
(No permission for publication)
Bumsik Chin, MD, PhD
National MEdical Center/Center for Infectious Diseases, Seoul
 Ruxrungtham,Kiat 2018 120x160Clinical experience INSTI in Thailand
Kiat Ruxrungtham, MD
Chulalongkorn University, Bangkok
 Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in Bangkok
Abstract | 02

Donn Colby
Thai Red Cross, Thailand
 Starting PrEP during acute HIV infection: what is the risk for antiretroviral drug resistance?
Abstract | 03

Donn Colby
Thai Red Cross, Thailand
 Dolutegravir plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV post-exposure prophylaxis: efficacy and safety results from real world study
Abstract | 04

Chongxi Li
Yunnan Third People’s Hospital, China
  
 Session 3: Drugs to Address Challenging Populations
Chair: Jonathan Schapiro & Bumsik Chin
 Rakhmanina, Natella 2017INSTI use in women of child-bearing age - NTD toxicity
Natella Rakhmanina, MD, PhD
Children’s National Health System, Washington, DC
 Chen, Jun 2019 120Clinical Utility of INSTIs in patients with multiple co-morbidities
Jun Chen, MD, PhD
Shanghai Public Health Clinical Center, Shanghai
 Lui Grace,2017Challenges in caring for HIV-TB coinfected patients
Grace Lui, MD, PhD
The Chinese University of Hong Kong, Hong Kong
 Khoo, Saye 2012Clinical case: HIV/TB Co-infection
(No permission for publication)

Saye Khoo, MD, PhD
University of Liverpool, Liverpool
  
 

Day 2 - Thursday, 27 June 2019

 Session 4: Next generation of Antiretroviral Treatment Strategies
Chair: Charles Boucher & Shinichi Oka
 Cahn, Pedro 2016 120x160Reduced drug regimens
Pedro Cahn, MD, PhD
Fundación Huésped, Buenos Aires
 Khoo, Saye 2012Update on long acting antiretroviral drugs
Saye Khoo, MD, PhD
University of Liverpool, Liverpool
 Boyd, Mark 2015INSTI Research in Asia - What are the remaining Gaps?
Mark Boyd, MD, FRACP
University of Adelaide, Adelaide